33164543|t|The probable role of insulin resistance and SIRT1 proteins in the Alzheimer's disease.
33164543|a|OBJECTIVE: Recent evidence suggests that insulin resistance may play an important role in the pathogenesis of Alzheimer's disease (AD). In this study, the probable role of insulin resistance in the pathogenesis of AD was investigated in patients with Type 2 Diabetes Mellitus (T2DM). METHODS: Serum amyloid beta (Abeta) (1-42), insulin like growth factor-1 (IGF-1), sirtuin1 (SIRT1) and leptin protein levels were measured in serum samples of control (n = 26), probable AD (n = 26), and probable AD+T2DM patients (n = 12) using ELISA method. Mini mental state examination (MMSE) was performed to the patient and control groups. RESULT: Serum IGF-1 significantly increased in the probable AD+T2DM group as compared to the control and probable AD groups (p   0.05). The levels of serum leptin significantly decreased in the probable AD and AD+T2DM groups as compared to the control (p   0.05). There were no statistically significant differences in serum Abeta (1-42) and SIRT1 levels among groups (p > 0.05). CONCLUSION: The significant decrease in serum leptin levels in AD patients may indicate that it may be a therapeutic marker in AD. The level of serum Abeta peptide and SIRT1 proteins can vary depending on the stage of the disease. Therefore, this study should be supported by more comprehensive studies in terms of the number of patients in advanced stage (Tab. 1, Fig. 4, Ref. 29).
33164543	21	39	insulin resistance	Disease	MESH:D007333
33164543	44	49	SIRT1	Gene	23411
33164543	66	85	Alzheimer's disease	Disease	MESH:D000544
33164543	128	146	insulin resistance	Disease	MESH:D007333
33164543	197	216	Alzheimer's disease	Disease	MESH:D000544
33164543	218	220	AD	Disease	MESH:D000544
33164543	259	277	insulin resistance	Disease	MESH:D007333
33164543	301	303	AD	Disease	MESH:D000544
33164543	324	332	patients	Species	9606
33164543	338	362	Type 2 Diabetes Mellitus	Disease	MESH:D003924
33164543	364	368	T2DM	Disease	MESH:D003924
33164543	386	398	amyloid beta	Gene	351
33164543	400	405	Abeta	Gene	351
33164543	415	443	insulin like growth factor-1	Gene	3479
33164543	445	450	IGF-1	Gene	3479
33164543	453	461	sirtuin1	Gene	23411
33164543	463	468	SIRT1	Gene	23411
33164543	474	480	leptin	Gene	3952
33164543	557	559	AD	Disease	MESH:D000544
33164543	583	585	AD	Disease	MESH:D000544
33164543	586	590	T2DM	Disease	MESH:D003924
33164543	591	599	patients	Species	9606
33164543	687	694	patient	Species	9606
33164543	729	734	IGF-1	Gene	3479
33164543	775	777	AD	Disease	MESH:D000544
33164543	778	782	T2DM	Disease	MESH:D003924
33164543	829	831	AD	Disease	MESH:D000544
33164543	871	877	leptin	Gene	3952
33164543	918	920	AD	Disease	MESH:D000544
33164543	925	927	AD	Disease	MESH:D000544
33164543	928	932	T2DM	Disease	MESH:D003924
33164543	1057	1062	SIRT1	Gene	23411
33164543	1141	1147	leptin	Gene	3952
33164543	1158	1160	AD	Disease	MESH:D000544
33164543	1161	1169	patients	Species	9606
33164543	1222	1224	AD	Disease	MESH:D000544
33164543	1245	1250	Abeta	Gene	351
33164543	1263	1268	SIRT1	Gene	23411
33164543	1424	1432	patients	Species	9606
33164543	Association	MESH:D000544	3479
33164543	Association	MESH:D000544	23411
33164543	Negative_Correlation	MESH:D003924	3952
33164543	Positive_Correlation	MESH:D003924	3479
33164543	Negative_Correlation	MESH:D000544	3952

